お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ

株式会社グローバルインフォメーション
市場調査レポート
商品コード
661181

世界の羊水穿刺針市場 - 針の種類、処置タイプ、エンドユーザー、地域別 - 成長、動向、予測

Amniocentesis Needle Market - Growth, Trends, and Forecasts (2020 - 2025)

出版日: | 発行: Mordor Intelligence Pvt Ltd | ページ情報: 英文 110 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.53円
世界の羊水穿刺針市場 - 針の種類、処置タイプ、エンドユーザー、地域別 - 成長、動向、予測
出版日: 2020年06月01日
発行: Mordor Intelligence Pvt Ltd
ページ情報: 英文 110 Pages
納期: 2-3営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

世界の羊水穿刺針市場の2018年から2023年のCAGR(複合年間成長率)は、約5.4%となる見通しです。羊水検査は、妊娠中期に羊水穿刺針を用いて胎児を取り囲む羊水を採取し、胎児の異常を診断するために行われます。

当レポートでは、世界の羊水穿刺針市場を調査し、市場の概要、針の種類・処置タイプ・エンドユーザー・地域別の市場規模の推移と予測、市場動向、成長要因・阻害要因ならびに市場機会・課題の分析、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 イントロダクション

  • 市場の定義

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 主な影響要因

第5章 市場の概要

  • 現在の市場シナリオ
  • ファイブフォース分析
    • 買い手の交渉力
    • 供給企業の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係

第6章 成長要因、阻害要因、市場機会、課題

  • 成長要因
    • 羊水検査の高い信頼性
    • 初産年齢の中央値の上昇
    • 先天性疾患の負担
  • 阻害要因
    • 代替法の利用可能性
  • 市場機会
  • 主な課題

第7章 市場セグメンテーション

  • 針の種類別
    • 100mm~150mm
    • 151mm以上
    • 99mm以下
  • 処置タイプ別
    • 羊水穿刺
    • 羊水除去
    • 胎児輸血
    • 羊水補充
    • 臍帯穿刺
  • エンドユーザー別
    • 病院
    • 診断センター
    • 診療所
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • その他の地域

第8章 競合情勢

  • M&A分析
  • 合意、コラボレーション、パートナーシップ
  • 新製品の発売

第9章 主要企業

  • Becton, Dickinson and Company
  • Biopsybell
  • Cook Medical
  • Coopersurgical
  • Integra Lifesciences
  • Laboratoire Ccd
  • Medline
  • Medtronic
  • Ri.Mos.
  • Rocket Medical
  • Smiths Medical
  • Tsunami Medical

第10章 市場の将来展望

目次
Product Code: 61500

The market for amniocentesis is expected to grow steadily over the forecast period. Certain factors that are responsible for the growth of this market are the growing median age of first-time motherhood, the increasing burden of the congenital diseases, and the high reliability of people on amniocentesis.

Amniocentesis is almost 99.4% accurate and this test determines if the baby in the womb has any genetic or chromosomal abnormalities. The test can identify many genetic disorders, such as Down syndrome, Edward's syndrome, Tay-Sachs disease, Huntington's disease, sickle cell disease, and cystic fibrosis. It can provide the information needed to diagnosis these complications in the fetus. Due to the high reliability of the test, its adoption is good across several healthcare facilities, therefore the market is expected to expand over the forecast period.

Key Market Trends

Amniocentesis Procedure is Expected to Show Steady Growth Over the Forecast Period

Rising concern about genetic disorders is the major factor responsible for the growing number of procedures. Various studies have been conducted by organizations such as the National Institute of Health (NIH) to understand the risks associated with amniocentesis procedure and the challenges during the same. Studies have revealed that the occurrence of early abortion after amniocentesis is a major risk and its prevalence is around 10%. However, the technical advancements in the needles, and the focus of medical professionals on the safety of the patient, it is expected that the instances of early abortions will be reduced in the near future. Furthermore, the increasing birth rate globally is enhancing market growth. India is the leading country in terms of having the highest birthrate.

Therefore, due to the increasing birth rate, rising number of amniocentesis procedures, growing adoption of the same, and increasing focus on patient safety, the amniocentesis procedure segment is expected to show steady growth over the forecast period.

North America to Maintain Lead in the Amniocentesis Market

The global amniocentesis needle market is dominated by North America and Europe respectively. North America will continue to dominate the global market over the forecast period. Factors, such as the rising government initiatives and an increasing number of amniocentesis procedures, are driving the growth of the market in this region.

The developed healthcare system in the United States is augmenting the demand for advanced products which is accelerating the growth of amniocentesis needles with advanced technology. Added to that, a concern of the general population in the North America region about the genetic disorders in a newborn is propelling the demand for amniocentesis procedure.

Competitive Landscape

The market for amniocentesis needles is moderately competitive and is comprised mostly of local companies. Countries like China and India are having a large number of local suppliers for the amniocentesis needles which is posing an intense competition among these local companies. The market is also witnessing the presence of global companies but the competition among the big players is comparatively lower than that of the local players.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 High Reliability of Amniocentesis
    • 4.2.2 Growing Median Age of First-Time Motherhood
    • 4.2.3 Increasing Burden of Congenital Disorders
  • 4.3 Market Restraints
    • 4.3.1 Availability of Alternate Methods
    • 4.3.2 Lack of Skilled Professionals
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Type
    • 5.1.1 100 to 150 mm Needles
    • 5.1.2 Larger Than 150 mm Needles
    • 5.1.3 Smaller Than 100 mm Needles
  • 5.2 By Procedure
    • 5.2.1 Amniocentesis Procedures
    • 5.2.2 Amnioreduction Procedures
    • 5.2.3 Fetal Blood Transfusion Procedures
    • 5.2.4 Amnioinfusion Procedures
    • 5.2.5 Cordocentesis Procedures
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 The Ccoper Companis Inc.
    • 6.1.2 Becton, Dickinson and Company
    • 6.1.3 Cook Medical Incorporated
    • 6.1.4 RI.MOS. Srl
    • 6.1.5 Smiths Medical
    • 6.1.6 Laboratoire Ccd
    • 6.1.7 Integra Lifesciences
    • 6.1.8 Medtronic Plc
    • 6.1.9 Medline Industries Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.